Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pleural Disorders: Types and Brief Description01:30

Pleural Disorders: Types and Brief Description

The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

EMBER-Lung: Electronic Medical Record Boosting Molecular Testing in Early-Stage Non-Small Cell Lung Cancer.

JCO precision oncology·2026
Same author

Fibroblast activation protein-targeted near-infrared labeling of cancer-associated fibroblasts in a non-small-cell lung cancer tumor microenvironment.

Scientific reports·2026
Same author

A Closer Look at Costs of California Hospital Operating Rooms.

JAMA surgery·2026
Same author

Intraoperative Nodule Localization in Non-Small-Cell Lung Cancer: Existing and Emerging Techniques.

Cancers·2026
Same author

Treatment Attrition From Surgery to Adjuvant Therapy in Stage IIB and IIIA Lung Adenocarcinoma: A National Cancer Database Analysis.

Clinical lung cancer·2026
Same author

3D Reactive Oxygen Species Dosimetry in Pleural Photodynamic Therapy: Integration of Macroscopic Kinetic Modeling and Deformable Registration.

Antioxidants (Basel, Switzerland)·2026

Related Experiment Video

Updated: Jul 23, 2026

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model
09:31

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Published on: October 2, 2015

Malignant mesothelioma: options for management.

Sunil Singhal1, Larry R Kaiser

  • 1Department of Surgery, University of Pennsylvania Medical Center, 3400 Spruce Street, 4th Floor Silverstein, Philadelphia, PA 19104, USA.

The Surgical Clinics of North America
|December 11, 2002
PubMed
Summary

Early diagnosis and tailored therapies are crucial for diffuse malignant pleural mesothelioma. Differentiating histological types and stages improves treatment outcomes, especially with immunotherapy and gene therapy.

More Related Videos

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
07:54

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

Related Experiment Videos

Last Updated: Jul 23, 2026

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model
09:31

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Published on: October 2, 2015

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
07:54

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

Area of Science:

  • Oncology
  • Thoracic Surgery
  • Medical Research

Background:

  • Diffuse malignant pleural mesothelioma is often treated as a single entity, irrespective of histology and stage.
  • This approach is suboptimal, unlike strategies for other cancers.
  • Early diagnosis and tailored treatment are essential for maximizing therapeutic efficacy.

Purpose of the Study:

  • To advocate for a shift towards individualized treatment strategies for malignant pleural mesothelioma.
  • To emphasize the importance of early diagnosis for optimizing treatment outcomes, including immunotherapy and gene therapy.
  • To explore the potential of novel therapeutic modalities and combinations.

Main Methods:

  • Review of current therapeutic approaches for malignant pleural mesothelioma.
  • Analysis of prognostic factors, including histological type and tumor stage.
  • Discussion of potential roles for immunotherapy, gene therapy, and multimodality treatment.

Main Results:

  • Pure epithelial mesothelioma patients show better prognosis and response to trimodality therapy.
  • Stage I patients may benefit from radical surgery combined with chemotherapy and radiotherapy.
  • Treatment strategies for sarcomatous and mixed histology require further investigation.

Conclusions:

  • Individualized treatment based on histology and stage is critical for malignant pleural mesothelioma.
  • Further research is needed to define optimal neoadjuvant/adjuvant therapies, including immunotherapy and gene therapy.
  • Multicenter trials and specialized centers are essential for advancing mesothelioma treatment.